Association of MMP3, MMP9, ADAM33, and TIMP3 polymorphisms with chronic obstructive pulmonary disease and its progression

Molecular Biology

Volumn 46, Issue 3, 2012, Pages 438-449

  Korytina, G F ^a   Tselousova, O S ^a,b   Akhmadishina, L Z ^a   Viktorova, E V ^c   Zagidullin, Sh Z ^b   Viktorova, T V ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^b BASHKIR STATE MEDICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

association; chronic obstructive pulmonary disease; disintegrin metalloproteinase; gene and environmental interactions; matrix metalloproteinases; tissue inhibitors of metalloproteinases

Indexed keywords

EID: 84862308438     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893312020082     Document Type: Article

References (39)

1. Puzyrev V. P., Freidin M. B. 2009. Genetic view on the phenomenon of combined diseases in man. Acta Naturae. 3, 57-63.
2. Shmelev E. I. 2009. Chronic obstructive pulmonary disease. In: Pyul'monologiya: natsional'noe rukovodstvo (Pulmonology: National Manual). Ed. Chuchalin A. G. Moscow: GEOTAR-Media, pp. 303-360.
3. www. goldcopd. com. GOLD Workshop Report: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2010.
4. Bhupinder S. 2010. Matrix metalloproteinases: An overview. Res. Rep. Biol. 1, 1-20.
5. Holgate S. T. 2010. ADAM metallopeptidase domain 33 (ADAM33): Identification and role in airways disease. Drug News Perspect. 23(6), 381-387.
6. Greenlee K. J., Werb Z., Kheradmand F. 2007. Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted. Physiol. Rev. 87(1), 69-98.
7. Parks W. C., Wilson C. L., Lopez-Boado Y. S. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Rev. Immunol. 4, 617-629.
8. Wang X., Li L., Xiao J., Jin C., Huang K., Kang X., Wu X., Lv F. 2009. Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population. BMC Med. Genet. 10, 132-139.
9. Brew K., Nagase H. 2010. The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim. Biophys. Acta. 1803(1), 55-71.
10. Noll W., Belloni D., Rutter J., Storm C., Schned A., Titus-Ernstoff L., Ernstoff M., Brinckerhoff C. 2001. Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am. J. Pathol. 158(2), 691-677.
11. Armstrong C., Abilleira S., Sitzer M., Markus H. S., Bevan S. 2007. Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke. 38(11), 2895-2899.
12. Joos L., He J. Q., Shepherdson M. B., Connett J. E., Anthonisen N. R., Pare P. D., Sandford A. J. 2002. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum. Mol. Genet. 11, 569-576.
13. Gnasso A., Motti C., Irace C., Carallo C., Liberatoscioli L., Bernardini S., Massoud R., Mattioli P. L., Federici G., Cortese C. 2000. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler. Thromb. Vasc. Biol. 20(6), 1600-1605.
14. Ganter K., Deichmann K. A., Heinzmann A. 2005. Association study of polymorphisms within matrix metalloproteinase 9 with bronchial asthma. Int. J. Immunogenet. 32(4), 233-236.
15. Su D., Zhang X., Sui H., Li F., Jin L., Zhang J. 2008. Association of ADAM33 gene polymorphisms with adult allergic asthma and rhinitis in a Chinese Han population. BMC Med. Genet. 9, 82.
16. Zhou M., Huang Sh., Wan H.-Y., Li B., Drng W., Li M. 2004. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of South China. Chin. Med. J. 117(10), 1481-1484.
17. Glantz S. A. 1998. Primer of Biostatistics, 6th ed. NY: McGraw Hill.
18. PLINK v. 1. 0. http://pngu. mgh. harvard. edu/~purcell/plink/contact. shtml#cite.
19. SNPStats. http://bioinfo. iconcologia. net/SNPstats-web.
20. Haploview 4. 2. http://www. broadinstitute. org/scientific-community/science/programs/medical-and-population-genetics/haploview/haploview.
21. Santus P., Casanova F., Biondi M. L., Blasi F., Di Marco F., Centanni S. 2009. Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease. Monaldi. Arch. Chest. Dis. 71(1), 15-20.
22. McAloon C. J., Wood A. M., Gough S. C., Stockley R. A. 2009. Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency. Ther. Adv. Respir. Dis. 3(1), 23-30.
23. Nerusu K. C., Warner R. L., Bhagavathula N., McClintock S. D., Johnson K. J., Varani J. 2007. Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. Exp. Mol. Pathol. 83(2), 169-176.
24. Yamashita C. M., Dolgonos L., Zemans R. L., Young S. K., Robertson J., Briones N., Suzuki T., Campbell M. N., Gauldie J., Radisky D. C., Riches D. W., Yu G., Kaminski N., McCulloch C. A., Downey G. P. 2011. Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis. Am. J. Pathol. Aug. 23 (Epub ahead of print).
25. Juran B. D., Atkinson E. J., Schlicht E. M., Larson J. J., Ellinghaus D., Franke A., Lazaridis K. N. 2011. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. Liver Int. 31(6), 785-791.
26. Zhu C., Odeberg J., Hamsten A., Eriksson P. 2006. Allele-specific MMP-3 transcription under in vivo conditions. Biochem. Biophys. Res. Commun. 348, 1150-1156.
27. Souslova V., Townsend P. A., Mann J., van der Loos C. M., Motterle A., D'Acquisto F., Mann D. A., Ye S. 2010. Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB. PLoS One. 5(3), e9902.
28. Schirmer H., Basso da Silva L., Teixeira P. J., Moreira J. S., Moreira A. L., Simon D. 2009. Matrix metalloproteinase gene polymorphisms: Lack of association with chronic obstructive pulmonary disease in a Brazilian population. Genet. Mol. Res. 8(3), 1028-1034.
29. Su L., Zhou W., Asomaning K., Lin X., Wain J. C., Lynch T. J., Liu G., Christiani D. C. 2006. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis. 27(5), 1024-1029.
30. van Eerdewegh P., Little R. D., Dupuis J., Del Mastro R. G., Falls K., Simon J., Torrey D., Pandit S., McKenny J., Braunschweiger K., Walsh A., Liu Z., Hayward B., Folz C., Manning S. P., Bawa A., Saracino L., Thackston M., Benchekroun Y., Capparell N., Wang M., Adair R., Feng Y., Dubois J., FitzGerald M. G., Huang H., Gibson R., Allen K. M., Pedan A., Danzig M. R., Umland S. P., Egan R. W., Cuss F. M., Rorke S., Clough J. B., Holloway J. W., Holgate S. T., Keith T. P. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 418, 426-430.
31. Puxeddu I., Pang Y. Y., Harvey A., Haitchi H. M., Nicholas B., Yoshisue H., Ribatti D., Clough G., Powell R. M., Murphy G., Hanley N. A., Wilson D. I., Howarth P. H., Holgate S. T., Davies D. E. 2008. The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J. Allergy Clin. Immunol. 121(6), 1400-1406.
32. Gosman M. M., Boezen H. M., van Diemen C. C., Snoeck-Stroband J. B., Lapperre T. S., Hiemstra P. S., Ten Hacken N. H., Stolk J., Postma D. S. 2007. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax. 62(3), 242-247.
33. Pabst S., Pizarro Touron C., Gillissen A., Lennarz M., Tuleta I., Nickenig G., Skowasch D., Grohé C. 2009. ADAM33 gene polymorphisms in chronic obstructive pulmonary disease. Eur. J. Med. Res. 14(4), 182-186.
34. Kassiri Z., Defamie V., Hariri M., Oudit G. Y., Anthwal S., Dawood F., Liu P., Khokha R. 2009. Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart. J. Biol. Chem. 284(43), 29893-29904.
35. Gill S. E., Huizar I., Bench E. M., Sussman S. W., Wang Y., Khokha R., Parks W. C. 2010. Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. Am. J. Pathol. 176(1), 64-67.
36. Segura-Valdez L., Pardo A., Gaxiola M., Uhal B. D., Becerril C., Selman M. 2000. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 117, 684-694.
37. Atkinson J. J., Senior R. M. 2003. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell. Mol. Biol. 28(1), 12-24.
38. O'Farrell T. J., Pourmotabbed T. 2000. Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-like domain and active site of gelatinase B. J. Biol. Chem. 275(36), 27964-27972.
39. Lagente V., Boichot E. 2010. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J. Mol. Cell Cardiol. 48(3), 440-444.